CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 11,280 shares at $98.54 ($1,111,531)
- 4 Planned sale CHAIRMAN & CEO sold 151,300 shares at an average $94.71 ($14,330,278)
- 4 Planned sale CHAIRMAN & CEO sold 402,494 shares at an average $92.92 ($37,400,327)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 36,783 shares at an average $92.16 ($3,389,975)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 96,000 shares at an average $93.09 ($8,937,067)
- 4 Planned sale CHIEF OPERATING OFFICER sold 103,585 shares at an average $92.93 ($9,625,790)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 36,260 shares at an average $94.43 ($3,424,091)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,404 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 15,144 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 15,144 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 4,029 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 4,007 shares (to pay taxes)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 4,600 shares at $80.30 ($369,380)
- 4 Gift Director gave 2,600 shares (gift)
- 4 Option exercise Director acquired 403 shares (option exercise)
- 4 Open-market sale Director sold 3,673 shares at $81.43 ($299,092)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 2,799 shares (option exercise)
- 4 Option exercise Director acquired 2,799 shares (option exercise)
Page 1 of 20 · 385 filings